Telbolife AMH 80 Tablet is a powerful triple-combination antihypertensive medication that effectively manages high blood pressure by targeting multiple mechanisms contributing to elevated blood pressure. It contains Telmisartan (80 mg), an angiotensin II receptor blocker (ARB), Amlodipine (5 mg), a calcium channel blocker, and Hydrochlorothiazide (12.5 mg), a thiazide diuretic. This combination is ideal for patients who require more than one agent to achieve optimal blood pressure control.
Telmisartan helps relax and widen blood vessels by blocking the action of angiotensin II, a substance that tightens blood vessels. Amlodipine lowers blood pressure by relaxing the muscles of the heart and blood vessels, reducing resistance. Hydrochlorothiazide aids in lowering fluid levels in the body by increasing urine output, which helps reduce blood volume and pressure.
This three-in-one therapy delivers comprehensive management of hypertension, especially in patients who are not adequately controlled on dual therapy alone. By acting on different physiological pathways, Telbolife AMH 80 not only provides consistent blood pressure reduction over 24 hours but also contributes to the prevention of complications such as heart attack, stroke, and kidney damage.
This medication should be taken once daily, preferably in the morning, with or without food. It is important to maintain a low-sodium diet, exercise regularly, and avoid smoking and alcohol to maximize the effectiveness of the treatment.
Routine monitoring of kidney function, electrolytes (especially potassium), and blood pressure is recommended during therapy. Patients should be educated about possible signs of dehydration or low blood pressure, particularly in hot weather or during illnesses that cause fluid loss.